Dr Dan Benjamin
Co-Founder and Chief Technology Officer, Immuto Scientific
Dan Benjamin is a technology developer who leads Immuto Scientific’s high-throughput structural proteomics and AI integration efforts for antibody discovery. His doctoral research in electrical engineering focused on developing radical labeling and protein footprinting approaches and applying them to industry applications, including epitope mapping.
Contact info
- Website:
- https://immutoscientific.com/
ArticleHow disease exposes hidden epitopes that AI models may miss
A protein can look very different in disease without a single change to its sequence. Measuring these structural changes could reveal drug targets invisible to genomic and expression data alone.